Literature DB >> 17699246

Large within-day variation in cyclosporine absorption: circadian variation or food effect?

John J Curtis1, Patsy Jones, Ralph Barbeito.   

Abstract

With the recent focus of monitoring cyclosporine (CsA) therapy using measures of CsA absorption, it is important to understand published reports of diurnal variation in CsA exposure. In 10 renal transplant patients, CsA concentrations were measured 0, 1, 2, 3, and 4 h after both the morning and the evening doses and in a repeat session at least 1 wk later. Both area under the curve for the final 4 h after cyclosporine dose and cyclosporine concentrate 2 h after the cyclosporine dose were more than two-fold higher after the morning dose in both sessions. Because the morning levels were collected in a fasted condition and the evening ones in a fed condition, the study was extended to collect evening levels after fasting. The area under the curve for the final 4 h after cyclosporine dose and cyclosporine concentrate 2 h after the cyclosporine dose values observed now were comparable to the morning fasted values. That the large diurnal variation was due to variation in food consumption, as opposed to a biologic circadian rhythm affecting CsA absorption, has significant implications for therapeutic drug monitoring.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17699246     DOI: 10.2215/CJN.01531005

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  2 in total

Review 1.  The Many Faces of Calcineurin Inhibitor Toxicity-What the FK?

Authors:  Samira S Farouk; Joshua L Rein
Journal:  Adv Chronic Kidney Dis       Date:  2020-01       Impact factor: 3.620

2.  Calcineurin inhibitors differentially alter the circadian rhythm of T-cell functionality in transplant recipients.

Authors:  Sarah Leyking; Karin Budich; Kai van Bentum; Stephan Thijssen; Hashim Abdul-Khaliq; Danilo Fliser; Martina Sester; Urban Sester
Journal:  J Transl Med       Date:  2015-02-06       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.